Glenmark Zantac generic recall comes as Congresswoman assails FDA for inaction

19th December 2019 Uncategorised 0

Concerns over the safety of the U.S. drug supply were recharged as Glenmark Pharmaceuticals initiated the recall all of nearly 2,000 lots of its Zantac generics from the U.S. market because they may contain elevated levels of a possible cancer-causing impurity. 

More: Glenmark Zantac generic recall comes as Congresswoman assails FDA for inaction
Source: fierce